Kazakhstan has made history by becoming the first country in the CIS and the fourth in the WHO European Region to achieve level III maturity for its national regulatory system for medicines.

The milestone confirms that Kazakhstan’s pharmaceutical framework now meets international standards for drug quality, safety, and efficacy, The Caspian Post reports via Kazakh media.

Key areas covered include drug registration, manufacturing inspections, and quality control, boosting confidence among global investors, producers, and healthcare organizations.

The achievement was announced at the India-Kazakhstan Pharmaceutical Business Forum in Almaty, attended by more than 60 Indian pharmaceutical companies.

The Kazakh Ministry of Healthcare continues to modernize the sector through investment, digitalization, innovative technologies, and transparent procurement processes. Currently, 3.6 million people receive free medicines under state programs, while in 2025, 15.6 million prescriptions were issued worth 262.9 billion tenge.